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INTRODUCTION
CD4+ lymphocytes can be subdivided into two
distinct populations, Th1 and Th2, defined by the
spectrum of cytokines produced by these cells inmice
(1, 2) and humans (3). Th1 cells generate interleukin
(IL)-2, interferon (IFN)-γ, and promote cellular immu-
nity, whereas Th2 generate IL-4, IL-5, IL-6, and IL-10,
and play a role in humoral responses and allergic
diseases (4, 5). There is evidence that a balance of
different cytokine producers is crucial for an effective
immune response and the outcome of infectious,
autoimmune, and allergic diseases (6, 7).
In granulomatous diseases including sarcoidosis,
there is evidence for a predominant Th1 response.
Indeed, lung lymphocytes from sarcoidosis patients
produce excessive amounts of IFN-γ and IL-2 (8-11).
However, in eosinophilic pneumonia, eosinophils
which are known to grow and be activated in the
presence of Th2 cytokines are accumulated and acti-
vated in the lungs. Both Th1 and Th2 lymphocytes
have been suggested to be responsible for the
pathogenesis of this disorder (12, 13). Here, we report
a patient with sarcoidosis associated with chronic
eosinophilic pneumonia (CEP) along with a brief
review of relevant literature.
CASE REPORT
A 38-yr-old man had complained of productive
cough since August, 1996. A chest radiograph
which was taken for a health check on July 4, 1997,
revealed diffuse pulmonary opacities with bil hilar
lymphadenopathy. He was admitted to Tokushima
University Hospital on Dec. 18, 1997 for further
examinations. He denied using any prescription
medications, and there was no history of allergic
diseases including bronchial asthma.
On admission, a physical examination revealed
swelling of several lymph nodes in right (rt) cervical
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and bil axillar regions. Leukocyte count, 5100 per μl
with 13.0% of eosinophils. Erythrocyte sedimenta-
tion rate was within the normal range (2 mm/h),
and serum C-reactive protein was slightly elevated
(0.39 mg/dl ; normal, <0.3). Slightly increased serum
angiotensin-converting enzyme (ACE) (29.6 U/L ;
normal, 7.7-29.4) and lysozyme (17.6 μg/ml ; normal,
4.2-11.5) were observed. Arterial blood gas analysis
revealed mild hypoxemia (PaO2 63.8 mmHg) with
normal PaCO2 level. Pulmonary function test revealed
decreased FEV1.0% (55.1%) and %DLco (57.7%). Chest
radiograph and computed tomographic (CT) scan
showed hilar and mediastinal lymphadenopathy,
bil diffuse nodularity, and infiltrates with rt lobe
predominance (Figure 1a). 67Ga-citrate scintigraphy
showed abnormal accumulations in bil supraclavicular
regions, parotis, hilar regions, and rt lung. Oph-
thalmological examination revealed mild uveitis.
Bronchoscopy with bronchoalveolar lavage (BAL)
and transbronchial lung biopsies (TBLB) was per-
formed on Dec. 18, 1997. The BAL was performed in
the segment of rt B5b with a total volume of 150 ml
of sterile 0.9% saline in three 50-ml portions (Table 1).
Fig.1. a) A chest radiograph (lt) and chest CT scan (rt) at the time of admission. Hilar and mediastinal lymphadenopathy, bil
diffuse nodularity, and infiltrates with rt lobe predominance are seen.
b) A chest radiograph (lt) and chest CT scan (rt) after therapy with corticosteroid. A significant reduction is seen in the
infiltrates, but only mild reduction is observed in diffuse nodular shadows and hilar and mediastinal lymphadenopathy.
Table 1. Bronchoalveolar lavage data
Dec 18, 1997 Feb 25, 1998
BAL bronchus
Recovery rate (%)
Total cells, x106
AM, x106 (%)
Lymphocytes, x106 (%)
Neutrophils, x106 (%)
Eosinophils, x106 (%)
CD4/CD8
rt B5b
88
55.0
6.7 (12.1)
26.9 (48.9)
1.3 (2.3)
20.2 (36.8)
1.0
rt B5b
67
21.0
2.1 (10.2)
18.3 (87.1)
0.1 (0.7)
0.4 (2.0)
0.7
AM ; alveolar macrophages
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The number of total cells was, 5.5 x
107 and the cell differential revealed
increased percentages of lymphocytes
and eosinophils. The ratio of CD4
to CD8 was 1.0. Histological exam-
ination for TBLB specimen revealed
noncaseating epithelioid granulomas
and eosinophilic infiltration (Figure 2).
Findings of special stains for acid fast,
fungal, and parasitic microorganisms
were negative.
Based on these findings, a diagnosis
of sarcoidosis combined with CEP
was made. Therapy was initiated with
prednisolone, 30 mg per day, from
January13, 1998, and maintained for
a week. Then, 2.5mg of prednisolone
dosagewas reduced every twoweeks.
The clinical course is summerized in
Figure 3. Cough symptoms rapidly
decreased following the treatment,
and the opacities in the peripheral
infiltrates on chest radiograph were
also promptly reduced. The swelling
of lymph nodes observed in the rt
cervical and bil axillar regions grad-
ually decreased. The number of
peripheral eosinophils and serum
ACE level were reduced. PaO2 and
FEV1.0% were improved. The BAL,
which was performed on Day 42
after corticosteroid therapy had begun,
showed a significantly decreased
percentage of eosinophils but the
high percentage of lymphocytes
remained (Table 1). Follow-up chest
radiograph and CT scan showed that
the infiltrates with rt lobe predomi-
nance were significantly decreased, but
only mild reduction was observed in
hilar and mediastinal lymphadenopathy
and diffuse nodular shadows (Figure
1b).
IFN-γ, IL-2, IL-4 and IL-5 in BAL
fluid were measured using ELISA
as previously described (14) (Table 2).
IFN-γ, IL-4, and IL-5 were detected
in the BAL fluid obtained before
the corticosteroid therapy. After the
therapy, IL-4 or IL-5 was not detectable
(the detection limit was 20 pg/ml),
but IFN-γ was detected at the a
Fig.2. a) A small noncaseating epithelioid granuloma surrounded by mild
lymphocytic infiltration (H.E., 66 x).
b) Eosinophilic infiltration (arrow heads) observed in bronchial epithelium
(H.E., 250 x).
Fig.3. Summary of clinical course
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similar level as observed before therapy. No IL-2
was detected during the course.
DISCUSSION
Our patient had clinical, roentgenographic and
immunological features of sarcoidosis associated
with CEP. Chest radiograph and CT scan revealed
hilar and mediastinal lymphadenopathy and bil dif-
fuse nodularity. Lung lesions were histologically
confirmed to be noncaseating epithelioid granulomas.
Ophthalmological examinatoin disclosed uveitis.
Serum ACE and lysozyme levels were elevated.
These findings were consistent with a diagnosis of
sarcoidosis. However, in our patient the infiltrates
showed rt lobe predominance on chest radiograph
and CT. Moreover, both lymphocytes and eosinophils
were increased in the BAL fluid, and eosinophilic
infiltration was histologically observed in the TBLB
specimen of the lung. From these findings, the
disease diagnosed was sarcoidosis associated with
CEP.
Davis et al. showed that over 5% of BAL eosinophils
were observed in 7% of patients with sarcoidosis (15).
Allen et al . also reported that 6% of patients with
sarcoidosis were found to have BAL eosinophilia,
but all had relatively modest percentages (less
than 8%) of eosinophils (16), indicating that BAL
differentials from patients with sarcoidosis rarely
include significant numbers of eosinophils. We
know of only one report which showed a case
diagnosed as CEP concomitant with sarcoidosis ;
the case had a prominently increased percentage
(94.2%) of BAL eosinophils (17).
Corticosteroid therapy rapidly reduced peripheral
pulmonary infiltrates with rt lobe predominance
on chest radiograph and the BAL eosinophil
percentage. However, diffuse nodularity and hilar
and mediastinal lymphadenopathy on chest radio-
graph and the BAL lymphocyte percentages did
not respond well to the therapy. The early response
of pulmonary sarcoidosis to corticosteroid has been
known to be poorer when compared with that of CEP
(18, 19). Therefore, the clinical course in our patient
indicated that corticosteroid therapy predominantly
reduced lung lesions caused by CEP, and the lesions
which did not respond to the therapy might indicate
a diagnosis of sarcoidosis.
In this case, increased IFN-γ, IL-4 and IL-5 were
detected in the BAL fluid. Corticosteroid therapy
reduced IL-4 and IL-5 to undetectable concen-
trations but not IFN-γ. The activation of Th1-type
lymphocytes is known to have an important role
in the development of sarcoidosis (20). IFN-γ is
suggested to be important in the activation of
macrophages, resulting in processing inflammatory
cell accumulation, granuloma formation, and
fibrogenesis (21, 22). Indeed, in the BAL fluid of
active sarcoidosis, only Th1 cytokines can be found,
but Th2 cytokines such as IL-4 and IL-5 cannot be
detected (12, 20, 23). However, CEP is characterized
by the accumulation of eosinophils in the alveolar
spaces and the interstitium of the lung. In the BAL
fluid from patients with CEP, IL-2, IFN-γ (Th1
cytokine) and IL-5 (Th2 cytokine) can be detected,
indicating that both Th1 and Th2 cells may be
responsible for the pathogenesis of this disorder
(12, 13). IL-5, a cytokine known to induce eosinophil
proliferation, differentiation and activation, is impor-
tant in eosinophilia in vivo (24, 25). IL-4 is known
to be the master cytokine of the Th2-type immune
response (2), and can stimulate eosinophil trans-
migration to the airway mucosa by enhancing the
expression of vascular cell adhesion molecule 1 (25)
and the release of eosinophil-survival stimulating
activity from bronchial epithelial cells (27). In this
case, IL-4 and IL-5 were elevated in the BALF, but
neither was detectable after the corticosteroid treat-
ment, correlated with the clinical course of CEP,
indicating that the Th2-related cytokines might be
responsible for eosinophil infiltration into the lungs.
In this case, radiographical lesions of pulmonary
sarcoidosis and IFN-γ levels in the BAL fluid did
not respond well to corticosteroid therapy, but
serum ACE levels were reduced by the therapy.
Serum ACE level is higher in clinically active than
in inactive disease. Since ACE is known to be
produced by epithelioid cells of granulomas (28),
serum ACE reflects the total-body granuloma burden
and not just the degree of lung involvement (29,
30). From these observations, corticosteroid therapy
Table 2. Cytokines in bronchoalveolar lavage fluid
Corticosteroid therapy
Cytokines Before After
interferon-γ
interleukin-4
interleukin-5
28a
49
179
27
<20
<20
aData are expressed as pg/ml
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might partially improve granulomatous lesions due
to sarcoidosis except in lungs.
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